Daye logo — Bringing a new Daye in gynae health ☀️

Daye

Bringing a new Daye in gynae health ☀️

Founded 2017 United Kingdom United Kingdom 123 employees Series A Total: $15.50M Biotechnology, Health Care +2

General Information

Company Name Daye
Founded Year 2017
Location United Kingdom United Kingdom +1
Employees 123
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series A

Get notified when Daye moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Daye

Daye is a female-founded gynae health start-up focused on addressing the gender health gap. Their flagship product, the world’s first pain-relieving tampon, has already assisted over 75,000 women & AFAB individuals to manage menstrual cramps. In addition to this, they have also launched a second-generation tampon that enables at-home detection of vaginal infections, STIs, and HPV. Looking ahead, Daye aims to create solutions for under-served gynae health conditions such as endometriosis, PCOS, and menopause. Their vision for the next five years includes building an ecosystem where every woman can monitor and improve her health via her smartphone. Having secured a £10.00M Series A investment on 26 October 2022, Daye has gained the support of notable investors such as Hambro Perks, Simplyhealth, Cross-Border Impact Ventures, Michelle Tempest, MMV Europe & Asia-Pacific, and Fiona Pathiraja. The company, based in the United Kingdom, operates within the biotechnology, health care, health and wellness, and women's health industries.

Taxonomy: Gynecological Health, Feminine Health, Menstrual Health, Vaginal Microbiome, At-Home Screening, Menstrual Pain Relief, STI Detection, HPV Screening, Endometriosis Solutions, PCOS Management, Menopause Support, Digital Health Platform, Female Health Tech, Microbiome Testing, Health Monitoring

Services & Products

Online Period Care Products
Vaginal Health Consultations
Gynae Health Expertise
Innovative Femtech Solutions

Target Customers

Women Individuals Seeking Gynae Health Support Eco-conscious Consumers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 6
Investor Investor Investor
•••• ••••
26 Oct 2022
Seed Round •••••• 4
Investor Investor Investor
•••• ••••
10 May 2019
Non Equity Assistance •••••• 1 •••• •••• 01 Jan 2018

Daye Alternatives & Competitors

Daye vs

Finally, her feminine flow has met its match. Protect the most precious Jewel in the world. You!

1 employees
Daye vs
Verbena
Verbena United States

Healthcare Your Way

36 employees
Health Care, Health and Wellness
Daye vs

Ayurveda FemTech that combines Content, Technology, Ayurveda for women to experience healthy periods...

Series A
120 employees
Health Care, Health and Wellness
Also compare with: Daye vs Hertility Hertility

FAQ About Daye

Bringing a new Daye in gynae health ☀️
Daye was founded in 2017.
Daye is headquartered in United Kingdom.
Daye operates in the following industries: Biotechnology, Health Care, Health and Wellness, Women's Health.
Daye has approximately 123 employees.
Daye has completed 3 funding rounds, raising a total of $15.50M. The latest funding stage is Series A.
Daye offers: Online Period Care Products, Vaginal Health Consultations, Gynae Health Expertise, Innovative Femtech Solutions.
Top alternatives and competitors to Daye include Dream 2 Live Wholesalers, LLC, Verbena, Gynoveda, Hertility, Samphire Neuroscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Daye and Dream 2 Live Wholesalers, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Daye and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy